Beijing Strong Biotechnologies,Inc. (SHE:300406)
China
· Delayed Price · Currency is CNY 12.38
+0.07 (0.57%)
Apr 29, 2026, 3:04 PM CST
SHE:300406 Revenue
Beijing Strong Biotechnologies,Inc. had revenue of 334.81M CNY in the quarter ending March 31, 2026, with 4.69% growth. This brings the company's revenue in the last twelve months to 1.37B, down -13.52% year-over-year. In the year 2025, Beijing Strong Biotechnologies,Inc. had annual revenue of 1.36B, down -18.29%.
Revenue (ttm)
1.37B
Revenue Growth
-13.52%
P/S Ratio
5.25
Revenue / Employee
1.25M
Employees
1,098
Market Cap
7.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.36B | -303.42M | -18.29% |
| Dec 31, 2024 | 1.66B | -82.69M | -4.75% |
| Dec 31, 2023 | 1.74B | 230.75M | 15.27% |
| Dec 31, 2022 | 1.51B | -88.51M | -5.53% |
| Jan 1, 2022 | 1.60B | 751.27M | 88.58% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 7.40B |
| Amoy Diagnostics | 1.20B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Cowealth Medical China | 656.38M |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Thalys Medical Technology Group | 1.25B |
| Dian Diagnostics Group | 10.10B |
| Guangzhou Kingmed Diagnostics Group | 5.91B |